Development Level

Tbio 3 | 10,625
Tchem 2 | 1,890

IMPC Term

decreased T cell number 1 | 31
increased CD4-positive, alpha ... 1 | 15
increased leukocyte cell numbe... 1 | 37

Disease

ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
sarcoidosis 3 | 358
Acquired immunodeficiency syndrome 2 | 164
Ankylosing spondylitis 2 | 138
Autoimmune Diseases 2 | 33
HIV Infections 2 | 100
Rheumatoid Arthritis 2 | 1,160
cutaneous lupus erythematosus 2 | 1,056
diabetes mellitus 2 | 1,663
interstitial cystitis 2 | 2,299
lung cancer 2 | 4,466
primary Sjogren syndrome 2 | 789
tuberculosis 2 | 1,557
Acute disseminated encephalomyelitis 1 | 8
Agammaglobulinemia 1 | 24
Amyloidosis 1 | 68
Arthropathy 1 | 34
Bronchiectasis 1 | 29
Brucellosis 1 | 24
CD40 deficiency 1 | 3
CD40 ligand deficiency 1 | 2
Chickenpox 1 | 6
Chikungunya 1 | 12
Chlamydia 1 | 18
Chloracne 1 | 32
Cholangitis 1 | 20
Cholera 1 | 33
Chorioretinitis 1 | 6
Chronic fatigue syndrome 1 | 29
Coccidioidomycosis 1 | 7
Conjunctivitis 1 | 18
Crimean-Congo hemorrhagic fever 1 | 10
Cryptosporidiosis 1 | 12
Diarrhea 1 | 155
Diphtheria 1 | 23
Dysentery 1 | 13
Dysgammaglobulinemia 1 | 9
Echinococcosis 1 | 28
Ehrlichiosis 1 | 9
Erythema multiforme 1 | 15
Exanthema subitum 1 | 3
Gastritis 1 | 44
Gastroenteritis 1 | 46
Hantavirus pulmonary syndrome 1 | 7
Heavy chain disease 1 | 6
Henoch-Schoenlein purpura 1 | 13
Hepatitis 1 | 61
Hepatitis A 1 | 10
Hepatitis D 1 | 10
Hepatitis E 1 | 11
Herpes simplex 1 | 19
Herpes zoster 1 | 7
Hyper-IgM Immunodeficiency Syndrome, Type 1 1 | 1
Immunoglobulin alpha deficiency 1 | 10
La Crosse encephalitis 1 | 6
Legionellosis 1 | 4
Leprosy 1 | 77
Lichen planus 1 | 17
Lyme disease 1 | 23
Lymphatic system disease 1 | 14
Macroglobulinemia 1 | 17
Measles 1 | 20
Meningoencephalitis 1 | 13
Monoclonal paraproteinemia 1 | 2
Mumps 1 | 10
Myelitis 1 | 8
POEMS syndrome 1 | 6
Parotitis 1 | 6
Pericarditis 1 | 14
Pertussis 1 | 17
Pharyngitis 1 | 17
Phlebotomus fever 1 | 6
Pneumocystosis 1 | 18
Poliomyelitis 1 | 11
Polyclonal hypergammaglobulinemia 1 | 5
Polyneuropathy 1 | 30
Psoriatic arthritis 1 | 83
Q fever 1 | 11
Reactive arthritis 1 | 7
Retinitis 1 | 9
Rheumatic fever 1 | 16
Rubella 1 | 14
Schistosomiasis 1 | 38
Schnitzler syndrome 1 | 3
Scrub typhus 1 | 7
Sinusitis 1 | 30
Sleeping sickness 1 | 37
Spinal cord disease 1 | 22
Spotted fever 1 | 7
Subacute sclerosing panencephalitis 1 | 10
Synovitis 1 | 38
Syphilis 1 | 18
Tetanus 1 | 66
Toxocariasis 1 | 6
Uveitis 1 | 103
West Nile fever 1 | 6
Wiskott-Aldrich syndrome 1 | 27
X-linked hyper IgM syndrome 1 | 5
cat-scratch disease 1 | 9

Tissue

Blood and immune system 5 | 17,995
Digestive Tract 5 | 18,473
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Nervous System 5 | 18,561
Urinary Tract 5 | 18,444
Cardiovascular System 4 | 17,958
Endocrine System 4 | 18,512
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115

Target Family

Non-IDG 5 | 11,971

Grant Application

7R01AR041974-11 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
CD40 ligand CD40LG Tchem Non-IDG -4.55502 36580.5 1095
T-cell-specific surface glycoprotein CD28 CD28 Tchem Non-IDG -1.85970 107.1 1174
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Killer cell immunoglobulin-like receptor 3DL3 KIR3DL3 Tbio Non-IDG -1.72233 55.3 0
Killer cell immunoglobulin-like receptor 3DL1 KIR3DL1 Tbio Non-IDG -2.16534 198.8 236